Patent 7501247 was granted and assigned to Schering on March, 2009 by the United States Patent and Trademark Office.
Provided are methods for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis. Also provided are methods of treatment with antagonists of IL-17 and/or IL-23.